---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-056205"
form_type: "8-K"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-20T00:16:10.793684+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Zura Bio posts updated corporate presentation for Jefferies conference

## Summary
- Updated corporate presentation filed as Exhibit 99.1 on June 4, 2025.
- Presentation titled 'Advancing Dual-Pathway Biologic Candidates' for Jefferies Global Healthcare Conference.
- No specific financial or pipeline milestones disclosed in the filing.

## SEC filing metadata
- accession: 0001104659-25-056205
- form_type: 8-K
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465925056205/0001104659-25-056205-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465925056205/tm2516644d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-056205
- JSON: https://secwatch.observer/filing/0001104659-25-056205.json
- Plain text: https://secwatch.observer/filing/0001104659-25-056205.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.